Importantly, among these, three of the patients had undergone liver transplant at transition (two had biliary atresia and one had alpha‐1‐antitrypsin deficiency); therefore, overall 10% of transplant patients were lost to follow‐up in tertiary services. This evidence concerns the gene SERPINA1 and biliary atresia.